Regulations.gov document
Memorandum re Separation of Functions and Ex Parte Communications; Carbadox
Other · FDA-2023-N-4742 · posted Jan 15, 2025
Key facts
| Document ID | FDA-2023-N-4742-0043 |
|---|---|
| Title | Memorandum re Separation of Functions and Ex Parte Communications; Carbadox |
| Document type | Other |
| Subtype | Memorandum |
| Agency | FDA |
| Docket | FDA-2023-N-4742 |
| Posted | Jan 15, 2025 |
| Comment period opens | Jan 15, 2025 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: